Plasma medicine - Opportunities and challenges for science and healthcare
Kong, M.G.,Laroussi, M.,Fridman, A.
DOI: https://doi.org/10.1109/PLASMA.2009.5227237
2009-01-01
Abstract:Summary form only given: Although ionized gases have been known to have biological effects for more than 100 years, their impact on the practice in healthcare service became very significant only recently. Today, plasma-based surgical tools are used for tissue reduction and blood coagulation as surgical procedures. Most significant however is the speed at which low-temperature gas plasmas are finding new applications in medicine and biology, including plasma sterilization, wound healing, and cancer therapies just to name a few. In the terminology of biotechnology, the "pipeline" is long and exciting. This presentation reviews the current status of the field through examples with a particular emphasis on plasma inactivation of microorganisms and biomolecules, for which comprehensive scientific evidence has been obtained. Many early speculations of biocidal plasma species have now been confirmed through a combination of optical emission spectroscopy, laser-induced fluorescence, mass spectrometry, fluid simulation and biological sensing with mutated bacteria. Similarly, fundamental studies are being performed to examine cell components targeted by gas plasmas, from membrane, through lipid and membrane proteins, to DNA. Scientific challenge is significant, as the usual complexity of plasma dynamics and plasma chemistry is compounded by the added complication that cells are live and constantly evolving. Nevertheless, the current understanding of plasma inactivation currently provides strong momentum for plasma decontamination technologies to be realized in healthcare. A very recent focus has been the use of low-temperature plasmas for manipulation of mammalian cells, for example, for wound healing and cancer therapies. Clinical trial data suggest that plasmas are effective in inactivating bacteria embedded in open wounds and as a result encourage more rapid wound healing. Plasma-triggered programmed cell death has also been observed, highlighting the possibility of plas- a-enabled cancer therapy. Whilst opportunities thus highlighted are significant and exciting, the undepinning science poses many open questions. Some of these will be reviewed and discussed. The presentation will then discuss main requirements for plasma sources appropriate for their biomedical applications, in terms of the control of glow-to-arc transition, plasma chemistry, the scope of scaling. Finally a perspective will be offered, in terms of both opportunities and challenges.for which comprehensive scientific evidence has been obtained.